Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

EBR Systems Inc

Healthcare AU EBR

0.38AUD
-0.09(19.15%)

Last update at 2026-06-05T06:10:00Z

Day Range

0.370.40
LowHigh

52 Week Range

0.431.48
LowHigh

Fundamentals

  • Previous Close 0.47
  • Market Cap211.77M
  • Volume6440485
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-52.02800M
  • Revenue TTM3.98M
  • Revenue Per Share TTM0.009
  • Gross Profit TTM 0.67M
  • Diluted EPS TTM-0.31

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -50.45625M -20.17269M -35.03526M -33.08660M -39.83537M
Minority interest - - - - -
Net income -50.45833M -20.17422M -35.03689M -33.08821M -39.83537M
Selling general administrative - 5.82M 6.70M 5.41M 3.14M
Selling and marketing expenses - - 6.89M 8.11M 6.81M
Gross profit 0.51M - - - -
Reconciled depreciation - 0.97M 0.75M 0.65M 0.38M
Ebit -47.69418M -38.31903M -25.41707M -24.27712M -15.24084M
Ebitda -47.27713M -37.73154M -24.66482M -23.62468M -14.85682M
Depreciation and amortization 0.42M 0.59M 0.75M 0.65M 0.38M
Non operating income net other - - - - -
Operating income -47.69418M -38.31903M -34.54895M -24.27712M -15.24084M
Other operating expenses 49.37M 19.02M 34.55M 27.39M 17.57M
Interest expense 5.84M 3.00M 4.48M 1.53M 19.01M
Tax provision - 0.00153M 0.00162M 0.00160M 0.00000M
Interest income - 3.18M 3.28M 2.46M 0.02M
Net interest income - -2.84868M -4.48373M 0.94M -18.99105M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.00207M 0.00153M 0.00162M 0.00160M 20.94M
Total revenue 1.67M 0.00000M 0.00000M - 0.00000M
Total operating expenses 48.20M 19.02M 34.55M 27.39M 17.57M
Cost of revenue 1.17M - - - -
Total other income expense net -2.76207M -2.47771M -0.48632M -7.28321M -3.65871M
Discontinued operations - - - - -
Net income from continuing ops - -40.79827M -35.03689M -33.08821M -39.83537M
Net income applicable to common shares - - - -33.08821M -39.83537M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 97.29M 73.56M 78.90M 71.68M 85.42M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 3.82M 1.97M 0.38M 0.61M 0.17M
Total liab 71.69M 49.20M 47.84M 27.73M 9.53M
Total stockholder equity 25.61M 24.36M 31.06M 43.95M 75.90M
Deferred long term liab - - - - -
Other current liab 5.82M 4.52M 4.32M 3.57M 3.01M
Common stock 0.05M 0.04M - 320.78M 319.41M
Capital stock - 0.04M 342.75M 320.78M 319.41M
Retained earnings -402.48759M -353.45768M -311.69613M -276.82768M -243.50751M
Other liab - - - 0.48M -
Good will - - - - -
Other assets - - - 0.59M 0.44M
Cash 5.80M 6.92M 14.58M 15.46M 78.24M
Cash and equivalents - - - 15.46M 78.24M
Total current liabilities 14.06M 8.33M 6.45M 5.93M 7.32M
Current deferred revenue - - - - 0.00000M
Net debt 52.83M 34.48M 25.09M 6.13M -73.43513M
Short term debt 1.18M 0.56M - 0.27M 2.60M
Short long term debt - 0.04M 0.02M 0.05M 2.41M
Short long term debt total 58.63M 41.40M - 21.59M 4.81M
Other stockholder equity 427.10M 376.90M - 0.79M 1.03M
Property plant equipment - - - 3.52M 3.89M
Total current assets 73.16M 64.47M 74.37M 66.59M 81.10M
Long term investments - 5.30M 1.13M 0.99M -
Net tangible assets - - - 43.95M 75.90M
Short term investments 47.43M 53.75M 57.74M 48.07M -
Net receivables 2.32M 0.44M 0.24M 0.44M 0.97M
Long term debt - 40.26M 39.65M 19.40M 0.07M
Inventory 13.80M 1.39M - 2.00M 1.72M
Accounts payable 7.05M 3.25M 1.86M 2.09M 1.71M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.95M 0.87M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.41M 2.06M 0.59M 0.59M 0.44M
Deferred long term asset charges - - - - -
Non current assets total 24.13M 9.09M 4.52M 5.09M 4.32M
Capital lease obligations - 1.10M 1.92M 2.14M 2.32M
Long term debt total - - - 19.40M 0.07M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 11.52M 1.11M -8.64099M -49.34781M -0.90681M
Change to liabilities - - - 0.73M 0.72M
Total cashflows from investing activities 8.11M 1.11M -8.64099M -49.34781M -0.90681M
Net borrowings -0.03700M 0.04M 20.00M 17.60M 20.02M
Total cash from financing activities 48.46M 32.48M 40.47M 17.01M 95.76M
Change to operating activities - - - 0.42M 0.39M
Net income -50.45833M -40.79827M -0.03504M -33.08821M -39.83537M
Change in cash -1.65760M -7.66121M -0.87759M -62.78600M 72.36M
Begin period cash flow 7.46M 14.58M 15.46M 78.24M 5.88M
End period cash flow 5.80M 6.92M 14.58M 15.46M 78.24M
Total cash from operating activities -55.04695M -41.22982M -32.69751M -30.35592M -22.14939M
Issuance of capital stock 48.83M 34.02M 21.62M 0.42M 80.93M
Depreciation 0.42M 0.97M 0.00117M 0.65M 0.38M
Other cashflows from investing activities - 1.39M -8.28694M -48.61763M 0.00520M
Dividends paid - - - -20.00000M -22.42455M
Change to inventory -13.25361M -2.84254M 0.00000M - -
Change to account receivables -1.94453M -0.21484M 0.09M - -
Sale purchase of stock - 34.51M 0.05M -0.21333M -4.90158M
Other cashflows from financing activities - -1.57479M -2.14910M 19.21M 22.13M
Change to netincome - - - 0.31M -0.70866M
Capital expenditures 3.81M 0.27M 0.35M 0.73M 0.91M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -9.18243M -2.14179M 0.00078M 1.15M 1.11M
Stock based compensation 3.05M 1.74M 0.00131M - -
Other non cash items 4.18M -0.99907M -32.66573M - -
Free cash flow -58.85839M -41.50326M -33.05157M -0.73018M -0.91201M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EBR
EBR Systems Inc		 -0.09 19.15% 0.38 - - 53.22 15.26 44.04 -3.6785
COH
Cochlear Ltd		 5.35 5.63% 100.45 18.01 19.23 2.66 3.26 2.73 11.29
4DX
4DMEDICAL Ltd		 0.05 1.28% 3.97 - - 388.17 37.59 394.80 -7.2899
AVR
Anteris Technologies Global Corp		 1.81 15.10% 13.80 - - 683.66 3.14 327.85 -5.1986
PNV
Polynovo Ltd		 -0.015 1.40% 1.05 107.00 35.97 5.30 8.89 5.28 106.03

Reports Covered

Stock Research & News

View All

Profile

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.

EBR Systems Inc

480 Oakmead Parkway, Sunnyvale, CA, United States, 94085

Key Executives

Name Title Year Born
Mr. Allan R. Will Exec. Chairman 1954
Mr. John G. McCutcheon Pres, CEO & Director 1961
Mr. Frank Hettmann Chief Financial Officer NA
Mr. Michael Hendricksen Chief Operating Officer NA
Dr. N. Parker Willis Ph.D. Chief Technical Officer NA
Mr. Andrew Shute Sr. VP of Global Field Operations NA
Ms. Madhuri Bhat Chief Regulatory Officer NA
Dr. Spencer H. Kubo M.D. Chief Medical Officer NA
Mr. Steve Sandweg Chief Commercial Officer NA
Mr. John H. Sellers Sec. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.